DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Longitudinal age differences in humoral responses to the COVID-19 vaccine in the elderly are lost after the third dose
Nursing home residents constitute an especially frail population at a high risk for severe COVID-19 disease,1 mainly due to multiple comorbid conditions and immunesenescence.2 Hence, many countries have considered the administration of booster doses of vaccines due to the lower levels of anti-S IgG antibodies achieved by elderly adults after two doses of vaccine and a faster waning immunity thereafter.3 A recent work published in this journal by Dimeglio et al.,4 showing anti-SARS-CoV-2 antibodies before and after the third dose of the vaccine, reported that elderly adults achieved similar levels of anti-S IgG titers after the booster dose than those achieved by younger participants, shedding light on the benefit of the administration of such vaccine booster. Here, we present additional longitudinal data reinforcing this concept., This work was supported by the Instituto de Salud Carlos III through the project “PI21/00357” (Co-funded byEuropean Regional Development Fund/European Social Fund “A way to make Europe”/“Investing in your future”). MMPB was supported by a postdoctoral contract from Consejería de Transformación Económica, Industria, Conocimiento y Universidades, Junta de Andalucía (DOC_01646). ABR, IOM and VGR were supported by Instituto de Salud Carlos III (Sara Borrell program CD19/00143, Rio Hortega program CM19/00051, and PFIS program FI19/00298, respectively). YMP was supported by the Consejería de Salud y Familias of Junta de Andalucía through the ‘‘Nicolás Monardes’’ program (RC‐0006-2021)., Peer reviewed
DOI: http://hdl.handle.net/10261/307762, https://api.elsevier.com/content/abstract/scopus_id/85147143708
HANDLE: http://hdl.handle.net/10261/307762, https://api.elsevier.com/content/abstract/scopus_id/85147143708